Innovation for Everyone

xista science ventures portfolio companies Syntropic and VALANX Biotech present their technologies as part of the "Innovation Corner" exhibition series,  at the Vienna Museum of Technology.

In a constantly changing world, new ideas and technological breakthroughs are of crucial importance. Innovation not only strengthens the economy, but also improves the quality of life for all of us and helps to overcome global challenges. The "Innovation Corner" exhibition format at the Vienna Museum of Technology offers Austrian start-ups and innovative companies a platform to present their pioneering technologies.

In this context, two start-ups from the xista innovation ecosystem, were invited. Their innovative approaches to the treatment of depression and the production of protein-based drugs can be seen at the Technical Museum until December, along with eight other projects from the fields of medical technology and life sciences.

A New Approach to Treat Psychiatric Diseases 

In Europe alone, around 90 million people suffer from depression, which places a heavy burden on both individuals and society. The current standard treatment is oral antidepressants, however 50% of patients relapse or do not benefit from the medication, which is often associated with severe side effects.

Syntropic's goggle-like technology on display in the museum is based on flickering light that sends signals to the brain innitiating the formation of new connections between neurons. This process, known as neuronal plasticity, helps the brain heal and tackles the causes of psychiatric illnesses such as depression. In the future, this innovation could offer a non-invasive, side-effect-free alternative to standard drug therapy.

Producing Drugs Specific, Fast and Safely

Proteins play a crucial role in all pysiological processes of the human body, from transporting nutrients to fighting disease. In modern medicine, proteins are used, for example, to increase the retention time of chemical substances in the body or to transport active substances specifically to diseased tissue.

The challenge is to design the connection between protein and drug - also known as conjugation - in a targeted and specific way. In the museum, VALANX Biotech communicates this complex process and their innovative solution with the help of a video game. By making small changes to the protein composition, the start-up can standardize the conjugation process, and thus carry out controllable, reproducible production of protein-based drugs.

Promotion of Innovation in Austria

Factors such as accessible technology transfer and the provision of financial resources and infrastructure, as made possible by the xista ecosystem, promote innovation and support new ideas and technological breakthroughs. An early start through youth education, a strong research culture and its communication in formats such as the "Innovation Corner" of the Vienna Museum of Technology continue to contribute to the culture of innovation in Austria. 

Visit the exhibition at the Vienna Museum of Technology and discover how Austrian start-ups are shaping the future of medical technology and thus making a significant contribution to solving global health problems.

Further exciting news from our ecosystem

Innovation for Everyone

xista science ventures portfolio companies Syntropic and VALANX Biotech present their technologies as part of the "Innovation Corner" exhibition series,  at the Vienna Museum of Technology.

In a constantly changing world, new ideas and technological breakthroughs are of crucial importance. Innovation not only strengthens the economy, but also improves the quality of life for all of us and helps to overcome global challenges. The "Innovation Corner" exhibition format at the Vienna Museum of Technology offers Austrian start-ups and innovative companies a platform to present their pioneering technologies.

In this context, two start-ups from the xista innovation ecosystem, were invited. Their innovative approaches to the treatment of depression and the production of protein-based drugs can be seen at the Technical Museum until December, along with eight other projects from the fields of medical technology and life sciences.

A New Approach to Treat Psychiatric Diseases 

In Europe alone, around 90 million people suffer from depression, which places a heavy burden on both individuals and society. The current standard treatment is oral antidepressants, however 50% of patients relapse or do not benefit from the medication, which is often associated with severe side effects.

Syntropic's goggle-like technology on display in the museum is based on flickering light that sends signals to the brain innitiating the formation of new connections between neurons. This process, known as neuronal plasticity, helps the brain heal and tackles the causes of psychiatric illnesses such as depression. In the future, this innovation could offer a non-invasive, side-effect-free alternative to standard drug therapy.

Producing Drugs Specific, Fast and Safely

Proteins play a crucial role in all pysiological processes of the human body, from transporting nutrients to fighting disease. In modern medicine, proteins are used, for example, to increase the retention time of chemical substances in the body or to transport active substances specifically to diseased tissue.

The challenge is to design the connection between protein and drug - also known as conjugation - in a targeted and specific way. In the museum, VALANX Biotech communicates this complex process and their innovative solution with the help of a video game. By making small changes to the protein composition, the start-up can standardize the conjugation process, and thus carry out controllable, reproducible production of protein-based drugs.

Promotion of Innovation in Austria

Factors such as accessible technology transfer and the provision of financial resources and infrastructure, as made possible by the xista ecosystem, promote innovation and support new ideas and technological breakthroughs. An early start through youth education, a strong research culture and its communication in formats such as the "Innovation Corner" of the Vienna Museum of Technology continue to contribute to the culture of innovation in Austria. 

Visit the exhibition at the Vienna Museum of Technology and discover how Austrian start-ups are shaping the future of medical technology and thus making a significant contribution to solving global health problems.

Pitch your idea

Investment process

1. Share your Information

Use the form to tell us about your startup. Our team will review the details provided and will get back to you as soon as possible. If you meet the required criteria, we’ll plan together the next steps of your funding journey.

2. Start the financing process

We start by inviting you to a meeting and gather more information relevant to conducting a due diligence process, evaluating your business plans, growth strategy, and financial forecasts. Together, we analyze and determine the essential details and deal structure to meet your unique financing requirements.

3. Raise capital

If we invest, we will likely lead your funding round and will help you to fill your round and guide you through the process. From round preparations to execution, our team is here to support you, ensuring a smooth and successful experience.

4. Go beyond financing

We will be your partner in everything you encounter while executing your plans. We offer continuous support and guidance as we firmly believe long-term succes is a shared mission.